Group One Trading
IPCI

Group One Trading’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Group One Trading’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-733
Closed -$4K – 5733
2018
Q1 		$4K Hold
733
– – ﹤0.01% 4574
2017
Q4 		$6K Sell
733
-250
-25% -$2.27K ﹤0.01% 4545
2017
Q3 		$10K Buy
+983
New +$14K ﹤0.01% 4313
2016
Q2 		– Sell
-342
Closed -$6.23K – 5139
2016
Q1 		$7K Sell
342
-869
-72% -$19.3K ﹤0.01% 4135
2015
Q4 		$25K Hold
1,211
– – ﹤0.01% 3809
2015
Q3 		$22K Buy
1,211
+1,019
+531% +$26.8K ﹤0.01% 3998
2015
Q2 		$6K Sell
192
-28
-13% -$846 ﹤0.01% 4467
2015
Q1 		$6K Buy
+220
New +$5.34K ﹤0.01% 4331
2014
Q3 		– Sell
-1,214
Closed -$35K – 5636
2014
Q2 		$46K Buy
1,214
+137
+13% +$5.28K ﹤0.01% 3612
2014
Q1 		$47K Buy
+1,077
New +$43.1K ﹤0.01% 3681

Other funds holding IPCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
VAM
Verity Asset Management Durham, North Carolina $238M AUM 24.8% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Group One Trading's IPCI Position: Q2 2018 in Review

Group One Trading sold out of Intellipharmaceuticals International Inc. (IPCI) in Q2 2018, closing a stake of 733 shares — an estimated $4K sold.

Group One Trading first reported a position in IPCI in Q1 2014 and held it in 10 quarters. The position peaked at $47K in Q1 2014. 24 funds tracked by Wall St. Rank hold IPCI as of Q2 2018.

  • Group One Trading reported no remaining Intellipharmaceuticals International Inc. position as of Q2 2018 after selling out during the quarter.
  • Group One Trading sold 733 Intellipharmaceuticals International Inc. shares in Q2 2018, an estimated $4K.
  • Group One Trading first reported a position in Intellipharmaceuticals International Inc. in Q1 2014 and held it in 10 quarters.
  • Group One Trading's Intellipharmaceuticals International Inc. position peaked at $47K in Q1 2014.
  • 24 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q2 2018.

Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.